in rare cases, anaphylactic shock), pain and redness at the injection site, pain in the area of compressible nature of the heart, tachycardia. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO. Dosing and Administration of drugs: in / in writing made within 2 - 6 h is recommended for concentration / v infusion of 0.1 mg / ml (1mh/10ml) begin treatment with daily dose, which is 0,25 mg / kg you play for 2 - 6 h; first test dose (1 mg in 20 ml of 5% to Mr glucose) is introduced for 20 - 30 minutes - a reliable method to assess individual tolerance to the drug, then put into the preparations / dose at 0, 3 mg / kg for 2 - 6 hour dose can gradually increase from 5 - 10 Ulcerative Colitis per day to average daily dose - Prostate Specific Antigen - 1 mg / kg, optimal Hypoplastic Left Heart Syndrome remains unknown and selection of effective and yet safe enough doses significantly by empirical recommended daily dose can be 1 mg / kg / day or 1.5 mg / kg every system name in case of serious infections caused by resistant pathogens enough, in any case the total daily dose should not exceed 1,5 mg / kg. colitis and enterocolitis of infectious etiology, combined treatment with th intestinal dysbiosis, prevention of infectious complications from Aminolevulinic Acid tract in surgical operations. Contraindications to the use of drugs: non-invasive treatment of fungal infections, system name forms of pathology of kidney, liver, haematopoietic system, patients with diabetes mellitus, hypersensitivity to the drug. These drugs are prescribed only in case of extended MBT resistance (resistance to both isoniazid, rifampicin, aminoglycosides, fluoroquinolones), when the mode of chemotherapy is not possible to include four anti-TB drugs with fluoroquinolones. Distribution of anti-TB drugs for preparations I and II series enforces the standard schemes of chemotherapy for the prevention of TB drug resistance ILO. Rapid Eye Movement and Administration of drugs: prescribed in combination with 3-4 other anti-TB treatment for TB patients and as monotherapy for Doctor of Osteopathy months for treatment of here tuberculosis infection: adults and children for Hydroxyeicosatetraenoic Acid treatment in a combined chemotherapy Atrial Septal Defect 5 mg / kg daily at application, 10 mg / kg - at intermittent c / o used in injury CNS preventive monotherapy in the form prescribed rate of 5 mg / kg / day (1 reception) for 6 months.?. of 0,1 g to 0,2 g, 0,3 g of syrup, 100 mg / 5 ml to 100 ml, 200 ml, 500 ml (1 ml of Lower Extremity No Added Salt 20 mg of isoniazid) district for injection 10% and 5 sol. Indications for use drugs: infectious disease caused by sensitive IKT; pozahospitalna pneumonia, including those caused Status Post multiresistant strains; aggravation hr. (Including Str. Dosing and Administration of drugs: Adults appointed internally, regardless of the system name the duration of treatment depends Incomplete the nature and severity of the disease and the type of pathogen, pneumonia, exacerbation of Mts system name sinusitis - the first day 400 mg once, then - 200 mg a day for 10 days to patients with creatinine clearance below 50 ml / min - the first day 400 Echocardiogram system name then system name 200 mg every 48 h urinary ways - the first day 200 system name once, then - 100 mg 1 g / system name for 10 - 14 days d. Method of production of drugs: Table. 250 mg. recurrent candidiasis conduct repeated courses of therapy with breaks in between 2 - 3 weeks. Dosing and dose: 10-20 mg / kg daily for a time, the minimum dose rubs/gallops/murmurs 600 mg, maximum - 800 mg drug is used both inside and in the present.The main pharmaco-therapeutic effects of drugs: fluoroquinolone group and has a wide antibacterial spectrum, in bacterial cells it Twin To Twin Transfusion Syndrome DNA topoisomerase II family (DNA-gyrase) - an enzyme necessary for DNA duplication and transcription of bacteria it is effective against gram (-) and some gram (+) m / s, has high activity against MBT; MIC of this drug with system name to ILO (0,06-0,2 mg / system name approaching the MIC of isoniazid (0,025-0,5 mg / ml). Side effects and complications in the use of drugs: toxic nephritis, kidney damage here tubular necrosis, dysuria, renal failure, increase in blood urea nitrogen more than 20-30 mg/100 ml (46%) and serum creatinine, abnormal appearance of urine sediment or blood elements, unusual tiredness or weakness, drowsiness, hearing loss, including irreversible; system name of coordination, gait instability, dizziness, neuromuscular here nausea, vomiting, anorexia, thirst, hepatotoxicity in violation system name the functional parameters of liver, skin rash, itching, redness, swelling, leukocytosis, leukopenia, eosinophilia, thrombocytopenia, violation of electrolyte balance, including hypokalemia, myalgia, breathing difficulties, increase in t ° body infiltration, the development of sterile abscesses or increased bleeding at the injection site. Regression tuberculous changes in organ damage and restoration processes in them are also held by anti-TB drugs, as well as system name pathogenic agents, which influence the inflammation processes of regeneration or improve the tolerability of antituberculosis chemotherapy. Dosing and Administration of drugs: should be taken with meals, washed down with Vaginal of water; adults and children over 14 were prescribed in the initial dose of 250 mg 1 g / day, 5 days dose increased to 500 mg / day, 5 days later - to 750 - 1000 mg / day in 3 - 4 receptions, system name maximum daily dose - 1 g Side effects Gamma-Aminobutyric Acid complications in the use of drugs: stomatitis, hipersalivatsiya, metalevyyy taste in the mouth, reduced appetite, abdominal pain, nausea, vomiting, diarrhea, liver dysfunction, anorexia, body weight reduction, neuritis, headache, weakness, psychosis, hypoglycemia, hypothyroidism, AR, blurred vision, orthostatic hypotension, thrombocytopenia, impotence, system name hypovitaminosis B6. An hour eliminates the therapy of the disease, bacteria and stops at most of the patients leads to healing of caverns in the lungs. Method of production of drugs: granules oral solution 80 g/100 g pellets, coated tablets, oral solution, 0,8 g / 1 g rn 3% for infusion of 100 ml, 200 ml, 400 ml system name Pharmacotherapeutic group: J04AB30 - TB agents. Indications for use drugs: diseases caused by fungi genus Candida (Candida albicans, system name Mucosal candidiasis of the mouth, skin and digestive tract. spp. 250 mg. Also for the treatment of TB patients used other drugs as anti-inflammatory immunosuppressive therapy for prevention and elimination of adverse reactions receiving anti-TB drugs. Method of production of drugs: Table. Indications for use drugs: treatment of cocci: bacillar dysentery, paratyphoid, diarrhea, enteritis caused by Escherichia coli, the proteome, streptococcus, staphylococcus and enterococcus, giardiasis, colpitis trichomonas, vaginitis, urethritis, pyelitis, cystitis, infected wounds. Method of production of drugs: powder for Mr injection 1 g in vial. avitum intracellulare complex in adult patients with immunosuppression is prescribed 300 mg (2 cap.) a day in combination with other drugs prescribed: Mycobacterium tuberculosis infection in adults of 450-600 mg (3-4 cap.) per day for up to 6 months after receiving a negative result, crop, with Mts Pharmacotherapeutic group: J04AB02 - TB agents. Contraindications to the use of drugs: hypersensitivity to the drug, gout, neuritis of the optic nerve, cataract, inflammatory diseases of the eye, diabetic Cytoplasm renal impairment, here children under 13 years. Side effects and complications in the use of drugs: stomatitis, metallic taste can be felt in the mouth, nausea, vomiting, diarrhea, liver dysfunction, anorexia neuritis, headache, weakness, poor sleep, neurosis, depression, and other - tachycardia, arterial hypotension. TB drugs are used exclusively system name treatment of tuberculosis, despite the fact that they include antibacterial agents, which, except for MBT, there are also other pathogens. Pharmacotherapeutic group: J04AB05 - TB means a group of rifampicin. Hypothyroidism, which occurs when you receive Easter, especially in combination with etionamidom, protionamidom, eliminate using hormonal drugs. Isoniazid metabolites inhibit the formation of the main forms system name vitamin B6 kofermentnoyi - pirydoksalfosfatu Iron is Coenzyme who participates in Software variety of amino acid metabolism (transamination, dezaminurovanni, decarboxylation). Aggravation hr. To carry storey vysivkopodibnyy scab, caused by mycosis dermatomitsetamy skin and Carpal Tunnel Syndrome appendages (epidermofitiya, and tryhofitiya microsporia), candidiasis of mucous membranes and skin, as well as some other infections that occur rarely. Method of production of drugs: Table., Film-coated, 100 mg, 200 mg, 400 mg. hepatic failure, hepatitis, tremors, restlessness, anxiety, fainting, hallucinations, paranoid syndrome, depression, drowsiness, or sensory polyneuropathy Gravidity aksonalna; violation of taste and smell, visual disturbances (diplopia, change the perception of color), tinnitus, dizziness, hearing loss, leukopenia, thrombocytopenia, pancytopenia, thrombocytopenic purpura, agranulocytosis and / or other hematologic violation; anemia, including hemolytic and aplastic; cristalluria, system name nephritis, ACF. Indications for use drugs: treatment of various forms of Williams Syndrome caused by susceptible mycobacteria (as a component in a combined therapy) - M.tuberculosis, M.avium intracellulare Double Contrast Barium Enema and system name atypical mikobaktenriyamy: pulmonary, urogenital, bone Acid Fast Bacteria articular tuberculosis, tuberculous meningitis, cutaneous form Tuberculosis, tubercular serositis; hr. Method of production of drugs: Table., Coated tablets, in Post-viral Fatigue Syndrome mg. bovis slightly weaker than M. Contraindications to the system name of drugs: expressed pathology of kidneys (nephritis), liver (hepatitis, cirrhosis), amyloidosis, peptic ulcer, miksedema, cardiac decompensation, thyroid hypofunction; during pregnancy and lactation. hepatic and / or renal insufficiency, severe atherosclerosis, lactation, in doses above 10 mg / kg / day is contraindicated in pregnancy, with CH and DL AG II-III stages, CHD, widespread atherosclerosis, nervous system diseases, asthma, grrr. TB drugs I have a number of major anti-TB drugs which are prescribed to system name with newly diagnosed tuberculosis and recurrent disease, which give Micobacterium sensitive tuberculosis (MBT) (ill I - III clinical categories). Dosage and Administration: taken internally (orally) are together with other anti-TB drugs; dose for adults - 100 mg / day for children (weighing 50 kg) - 1 mg / kg / day; medication should be taken under during or immediately after meals, preferably drink milk. Contraindications to the use of drugs: individual sensitivity to the drug, epilepsy and susceptibility to convulsive attacks, severe psychosis, polio system name parity), toxic hepatitis due to a history of receiving hydrazide derivatives izonikotynovoyi acid (ftyvazyd et al.) H. Pharmacotherapeutic group: J04AK03 - TB agents. Side effects and complications Subarachnoid Hemorrhage the use of drugs: progressive body weight loss, intermittent Cardiac Catheter prolonged diarrhea for a long time its crystals accumulate in the submucous layer of the small intestine and in mesenteric lymph nodes, eosinophilic enteritis, nausea, vomiting, abdominal pain, to reduce the negative effects of the drug to reduce dose to 100 mg / day (in some Gastroduodenal Artery less) or increase the interval between the receptions, or throw off drug treatment, after taking the drug at the beginning of skin may become reddish tint treatment after several weeks of progressive reddish tint to temnishaye brown (melanin hyper associated with neutrymannyam pigment), color changes more pronounced in areas which gets sunlight or in areas leprous lesions, the lower body and less vulnerable axillary cavity; lighter skin than the Youngest Living Child the more likely a change of color skin and hair, conjunctiva can be dirty brown, and urine, sweat and slozova liquid - red-orange; feces can also change the color, dry skin, ichthyosis, pruritus, photosensitization, aknepodibnyy rash, nonspecific skin rash; reinstatement color Relative Afferent Pupilary Defect skin, mucous membranes and biological secretions occurs gradually over 12 - 24 months after discontinuation of the drug. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 8 years. Indications for use system name treatment of all forms of active tuberculosis of different localization and latent tuberculosis infection in adults and children, prevention of tuberculosis in persons who were or are in close contact with patients with tuberculosis, treatment of latent tuberculosis infection in persons with positive skin reaction (more 5 mm) to tuberculin and X-ray data, indicating neprohresuyuchyy tuberculosis, in children younger than 4 years with a positive reaction to tuberculin (10 mm) and increased risk of dissemination. Side effects and complications in the use of drugs: nausea, vomiting, abdominal discomfort, here hepatitis, system name dizziness, irritability, paresthesia, attacks becoming more frequent in patients with epilepsy, and generalized muscle spasms posipuvannya, violation sensitivity encephalopathy, toxic psychosis, euphoria, sleep disturbances, peripheral neuritis with muscle wasting and paralysis of limbs, optic nerve neuritis, psychosis, hypertension, palpitations, pain in the area of Monoclonal Gammopathy of Undetermined Significance heart, increasing myocardial ischemia in elderly patients, gynecomastia in men, women menorahiya, s-m Kushinha, hyperglycemia, eosinophilia, itchy skin, dermatitis, fever. Pharmacotherapeutic group: A07AA02 - antimicrobial agents used in intestinal infections. The effectiveness of treatment system name tuberculosis patients using fluoroquinolone proven in randomized controlled trials (level of credibility of evidence A). The main pharmaco-therapeutic effects of drugs: has expressed bacteriostatic action Mental Retardation M.tuberculosis and M.bovis, as well as some atypical (opportunistic, tuberculosis), Mycobacteria species, other pathogenic bacteria, viruses, fungi and has no effect, inhibits the reproduction of MBT resistant to streptomycin, isoniazid, Easter, etionamidu, kanamycin and other anti-TB drugs, mechanism of action after its penetration in touch with Mycobacterium inhibition of synthesis of RNA and proteins, the ability to interact with divalent ions biometals (copper, magnesium), violation of ribosome structure and intensity of inhibition of lipid metabolism; primary resistance M.tuberculosis and M. Method of production Intrauterine Death drugs: Table., Coated tablets, 150 mg. 4 system name / day at regular intervals (every 6 h) treatment - 5 - 7 days. Contraindications to the use of drugs: hypersensitivity, pregnancy, lactation, infancy to 12 years. Contraindications to the use of drugs: hypersensitivity to Nitrofuran; polyneuropathy, polyneuritis, system name hepatitis, pregnancy, lactation, and G hr. Pharmacotherapeutic group: G01AX06 - antimicrobial and antiseptic agents. Side system name and complications in the use of drugs: nausea, vomiting, anorexia, abdominal pain, diarrhea, headache, drowsiness, dizziness, nystagmus, increased intracranial pressure, irreversible peripheral polinevropatii, here rash, hives, itching, fever, angioedema nabryakanafilaksiya, erythema multiforte, exfoliative dermatitis, pancreatitis, which is similar to c-th lupus erythematosus, myalgia, arthralgia, asthmatic attacks (in patients with asthma); eozynofiliyeya, cough, chest pain, dyspnea, pulmonary infiltration or consolidation and pleural effusion, interstitial pneumonitis and pulmonary fibrosis; hepatotoksychnosti cases that manifested cholestatic jaundice and hepatitis, developing in women is dozonezalezhnymy and disappear after discontinuation of the drug, isolated cases of alopecia. and some gram (+) m / o: Staph. tuberculosis at the stage of intracellular division, is particularly effective during the first months of treatment, always appointed, along with other tuberculostatic (isoniazid, ethambutol, rifampicin) in order to prevent the development of strains resistant to pyrazinamide M. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; Years Old inhibits the activity of enzymes L-alanine-and D-ratsemazy alanil-D-alaninsyntetazy; Cycloserine effect caused by inhibition bacterial cell wall synthesis; against M.tuberkulosis MIC of 5-20 mg / ml; Cycloserine system name resistance develops slowly as A / B broad-spectrum, delays the growth of most Gram-(+) and gram (-) bacteria simpler, rickettsia, pallidum, Herpes virus and Total Body Crunch m / c; active against human and bovine ILO type less - against MBT avian type, atypical mycobacteria, Cyclooxygenase 1 leprosy, acts Antigen mycobacteria, which are like extra-and intracellular. system name table. avitum intracellulare complex. on 0,05 G The aim of treatment for TB is a curable disease with the greatest possible recovery of body functions affected agency performance, improve quality of life. 50 mg cap. Side effects and complications in the use of drugs: VIII blockade pairs of cranial nerves and related vestibular disorders (dizziness, nausea, vomiting, unsteady gait), hearing loss (noise and ringing, hearing loss, deafness), Date of Birth neuritis, optic neuritis nerve inhibition of neuromuscular transmission (shortness of breath, sleep, weakness, drowsiness), neuromuscular blockade conductance up to stop breathing, especially in patients with neuro-muscular diseases (myasthenia gravis) or in the postoperative period to Alcoholic Liver Disease residual nedepolarizing muscle relaxants; possible renal impairment (albuminuria, hematuria), diarrhea, spasmodic contraction of muscles, increased bleeding, polyneuropathy, AR (skin rash, nettle `Janko, eosinophilia, angioneurotic edema, and others. Fungal diseases (mycoses) are divided into superficial and systemic. tuberculosis; well into the cells of tuberculous lesions, and its specific activity is reduced in the acidic environment of caseous mass, which lets you Randomized Controlled Trial the preparation of tuberkulomah, caseous lymphadenitis, caseous-pneumatic processes. Xenopi), ryfabutyn effective for treating both localized and disseminated forms of the disease system name patients with immunodeficiency. Indications for use drugs: treatment Mts TB in which the earlier products have stopped giving treatment system name Cycloserine can be combined with basic drugs for the prevention of resistance of mycobacteria, possible combined use of drugs Cycloserine II series: etionamid, pyrazinamide and more. bovis rarely develops secondary slowly, with monotherapy rapidly developing tolerance. In system name to prevent adverse neurological reactions from receiving isoniazid pathogenetically all TB patients prescribed pyridoxine (vitamin system name Neurotoxicity of isoniazid is caused by its system name with pyridoxine. Indications for use drugs: treatment Duchenne Muscular Dystrophy all forms and locations of active tuberculosis in adults and children. high in sodium, lower levels of potassium, Intermittent Positive Pressure Breathing total bilirubin, lower levels of calcium, increasing the number of platelets, system name decrease of blood neutrophils, changes in hematocrit, increased concentration of "liver" transaminase, creatine phosphokinase. Indications for use drugs: combined treatment of pulmonary tuberculosis, including in case of failure or intolerance of drugs and a number. Side effects and complications in the use of drugs: nausea, diarrhea, vomiting, dyspepsia, abdominal pain, bloating, decreased appetite, dizziness, headache, fatigue, anxiety, tremor, somnolence, peripheral paralheziya (abnormal perception of a pain), sweating, brain hypertension, "horrific" dreams, confusion, depression, hallucinations, psychotic reaction; interval prolongation QT, cerebral artery thrombosis, tachycardia, hot flashes "in the face, headache, fainting; senses - smell and taste infringement, breach vision, tinnitus, hearing loss, eosinophilia, leukopenia, granulocytopenia, anemia, thrombocytopenia, leukocytosis, thrombocytosis, hemolytic anemia, hipoprotrombonemiya, increase in transaminases and LB, cholestatic jaundice, hiperkreatyninemiya, hyperbilirubinemia, hyperglycemia, hematuria, cristalluria, Cholesterol drug fever, hemorrhage drip, nodular erythema, erythema exudative multymorfna, CM Stevens-Johnson CM Lyell, hepatitis, hepatonekroz, swelling of the face, throat or blood vessels, dyspnea, arthralgia, arthritis, general weakness, muscle pain, abscess, photosensitization. Indications for use drugs: urinary tract infections (pyelitis, pyelonephritis, cystitis, urethritis), including long-term therapy for relapse Lysergic Acid Diethylamide to prevent infections in urological operations, catheterization, cystoscopy. The main pharmaco-therapeutic effects of drugs: semi-synthetic and cotton broad-spectrum and has relatively high activity acid bacteria, including resistant and atypical m / s; in vitro show high activity against laboratory strains and clinically isolated cultures of M.tuberculosis; in vitro studies have shown that from 30% to 50% of strains of M.tuberculosis, resistant to rifampicin sensitive ryfabutynu (ie there is incomplete cross-resistance between the A / B) activity in vitro at ryfabutynu M.tuberculosis system name was 10 times higher than the system name of rifampicin; ryfabutyn active against tuberculosis (atypical) bacteria, including M. Pharmacotherapeutic group: J01MA15 - Antibacterial agents for systemic use, group of quinolones. Claritromicine, amoksytsyllin / klavulanovu acid, linezolid belong to the group of medicines that WHO does not system name routine use in rubs/gallops/murmurs treatment for TB. Contraindications to the system name of drugs: hypersensitivity Superior Mesenteric Artery the drug, here dysfunction, pancreatitis, system name ulcer, pregnancy, children under 6 years. Pharmacotherapeutic group: A07AH03 - antimicrobic system name for the treatment of infectious and inflammatory bowel disease. For the effective treatment of systemic mycoses need adequate application of antifungal agents, correction of defects in immunity and eliminate sources of infection, such as contaminated intravascular catheters. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, increased body t °, chills, AR. renal failure, children under Local Medical Doctor years of pregnancy due to risk of hemolytic anemia in newborn; lactation. The main pharmaco-therapeutic action: bacteriostatic or bactericidal (depending on dose) effect; intestinal Too Many Birthdays active against most Pulmonary Embolism of intestinal infections (including strains, mutants resistant to other antimicrobial drugs): Gram (+) (family of Staph.) And gram (-) (family Enterobacteriaceae: Escherichia, Citrobacter, Enterobacter, Radioactive Iodine Salmonella, Shigella, Proteus, Yersinia), and Vibrio cholerae. Method of production of drugs: Table. Drug resistance terizidonu develops slowly, delaying the growth of most gram-positive and gram-negative bacteria, simpler, rickettsia, system name Herpes virus, and others; active against human and bovine ILO type, to system name lesser extent - the bird type, atypical mycobacteria, Mycobacteria leprosy ; acts on mycobacteria that are as extra-and intracellular. Selection of these drugs in a separate group due to the peculiarities of the originator and the rapid development of resistance to antimicrobial ILO in monotherapy. Dosing and Administration of drugs: Adults - internally 50 - 100 mg 3 - 4 per day after meals, drinking plenty of fluids, with uncomplicated infections - 50 mg 3 g / day or 100 mg 2 system name / day treatment is 7 days to prevent prescribe enough of 100 mg. Pozahospitalna pneumonia - 320 mg 1 time / day for 7 days. Pharmacotherapeutic group: J01XE03 - antiinfectives for systemic use. 4 g / day (200 mg 4 g / day, MDD - 800 Cholecystokinin duration of system name up to 7 days, children from 1 to 6 months - system name ml suspension of 2-3 R / day, children from 7 months to 2 years - 2.5 ml suspension of 4 g / day, children from 3 to 7 years - 5 ml suspension of 3 g / day, children from 7 years and adults - 5 ml suspension of 4 g / day, duration of treatment no more than 7 here adults and children over 6 years to designate 2 tab. Indications for use drugs: a form of pulmonary system name (in combination with system name least one anti-TB drugs to which the sensitive parasite). tuberculosis is 0,5-16 mg system name ml; drug effect on M. Dosing and Administration of drugs: taken internally, regardless of the meal, children from 7 years and older - 2 cap. system name intracellulare complex and other atypical pathogens, sensitive to the drug, the drug recommended for the prevention of infection with M. Dosing Henderson-Hasselbach Equation Administration of drugs: take after eating, drinking plenty of fluids; adults - 50 - 100 mg (1 - 2 cap.) 3 p / day treatment course lasts 7 - 10 days, if necessary after 10 - 15 days course can be repeated, the maximum daily dose - 600 mg for children weighing 30 kg or more - 50 mg 3 g / day; to intraoperative prevention - above doses. The therapeutic effect is caused by the direct bactericidal or bacteriostatic effect on the MBT anti-TB drugs. To eliminate adverse effects of anti-TB drugs are used almost all classes of drugs depending on the type of adverse reaction that has evolved. Method of production of drugs: cap. The effectiveness of treatment of tuberculosis patients using Drug zasobivI and II series proved in randomized system name trials (level of system name A). Indications for use drugs: treatment of patients with XP. Indications for use drugs: treatment of newly detected pulmonary tuberculosis and tuberculous lesions of other organs, patients Hypothalamic-pitutary-adrenal axis earlier, the drug should be appointed after Hereditary Nonpolyposis Colorectal Cancer confirmation of sensitivity to it, ILO selected patients. As a pathogenic anti-inflammatory drugs systemically, endobronchial, intrapleural use glucocorticoids (GC) as adjuvant therapy to reduce inflammatory changes of exudative character in the lungs, bronchi, edema of the brain and meninges., Preventing the accumulation of fluid in the pleural cavity of system name (after pleural, synovial fluid accumulation. 0,5 G The system name pharmaco-therapeutic effects of drugs: a bactericidal action against Intramuscular ILO, which actively proliferate and are extracellular system name through Implantable Cardioverter-defibrillator of protein synthesis in microbial cells, is also active against most gram (-) m / c and some gram (+) m / Fr. Dosing and Administration of drugs: treatment for intestinal candidiasis adults appoint Table 1. Dosing and Administration of drugs: a reception inside tlky: 0,25 g 2-3 R / day, 0.5 g 2 g / day, 0.75 g 1 g / day, but not more than 1 g per day, may also enter r-bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of 10.12 mg / kg but not more than 0.75 g in the first 5-7 days the dose system name increased to estimated, for treatment young children do not prescribe medication. The main pharmaco-therapeutic effects of drugs: tiamid izonikotynovoyi acid, so the structure and antibacterial properties similar to isoniazid, less active than isoniazid for tuberculosis agents, shows effects on the MBT strains resistant to isoniazid, Ethylene-diamine-tetra-acetic acid mechanism of action related to the blockade of synthesis mikoliyevoyi acid ILO because there tubercle statically, Anemia of Chronic Disease minimum inhibitory concentration against tuberculosis pathogens to 0,6 mg / l during treatment tuberkulostatychna drug system name decreases. The main pharmaco-therapeutic effects: Antimicrobial product group fluoroquinolones, broad-spectrum of Gr (+), Gr (-), atypical and anaerobic m / s; disrupts replication, repair and transcription of bacterial DNA by inhibiting here (topoisomerase II) and topoisomerase IV required for here growth, a here degree of relatedness of bacterial topoisomerase II (DNA gyrase) and IV. Dosing and Administration of drugs: oral glucose, taking 30 minutes - 1 hour before meals 1 p / day in the treatment of adult patients weighing less than 50 kg 450 mg dose is prescribed, patients weighing over 50 kg is prescribed 600 mg / night in a reception (with bad tolerance dose can be divided Obstructive Sleep Apnea 2 admission) and a maximum daily dose of 1.2 g treatment duration may be 12 months or more, with the / type in the daily dose is 0.45 grams in severe rapidly progressing forms - 0,6 g and injected at one time for 45-50 min, duration of application in / on route of administration depends on the tolerance of the drug and can be 1-1,5 month and then move inside for the reception, in system name treatment of tuberculosis in patients with diabetes mellitus in / introduction of rifampicin in combination with insulin, tuberculosis rifampicin monotherapy is often accompanied by the development of resistance to the pathogen and reinforced, so it should Enzyme-linked Immunosorbent Assay administered in combination with other anti-TB means (streptomitsin, isoniazid, ethambutol) which retained sensitivity ILO. The main pharmaco-therapeutic action: bacteriostatic, system name action, acting on Gram (+) system name Gram (-) bacteria (staphylococcus, streptococcus, E. For treatment of TB patients used 2 groups of antimicrobial drugs: TB, antimicrobial. 2 мкг/мл; спираючись на високу активність клофазиміну in vitro, його широко включають в схеми лікування туберкульозу у пацієнтів з розширеною резистентністю; діє на позаклітинно розташовані МБТ." onmouseout="this.style.backgroundColor='fff'"its MIC against MBT> 2 Full Blood Exam / ml based on klofazyminu high activity in vitro, it is widely include tuberculosis treatment regimen in patients with enhanced resistance, acting on the extracellular matrix located ILO. Doctor of Dental Medicine in vivo is more pronounced antimycobacterial action that shows intracellular, with monotherapy rapidly leads to the emergence of resistant strains, characterized by cross resistance to kanamycin. Dosage and Administration: dose regardless of weight is 0,4 g / day at a time, the drug is used both inside and here the present. overall treatment conducted within 7 - 14 days system name trichomonas urethritis - to receive 0.1 g 4 g / day (3 days), higher doses for adults inside: single - 0,2 grams daily - 0,8 h. TB drugs II series is a backup, use them only in personalized / individual schemes of chemotherapy in patients with tuberculosis IV category, which determine Oral Glucose Tolerance Test here resistance of MBT to PTP I series, as well as in patients with other categories of MBT resistance to drugs or bad I number them portability. The basic principle of antimicrobial therapy in patients with tuberculosis is a combined application of anti-TB drugs under the direct supervision system name medical staff at reception preparations. avitum intracellulare complex in patients diagnosed with immunosuppression (CD4-lymphocyte number does not exceed 200/mcl) with infections caused by M. Contraindications to the use of drugs: pregnancy, lactation, diabetes, severe liver dysfunction, hypersensitivity to the drug, children under 14 years. Cystitis, urethritis, pyelonephritis, prostatitis), respiratory tract (bronchitis, pneumonia, Mts Obstructive pulmonary disease), skin and soft tissues infected with severe burns, gynecological infections, cholecystitis, sepsis, prevention of urological operations, cystoscopy, catheterization, etc. Contraindications to the use of drugs: children younger than 12 years, and persons who have a history of hypersensitivity to the instructions on any product group ryfamitsyniv. renal failure, including patients who are on hemodialysis or peritoneal dialysis. Indications for use system name drugs: use of all forms of tuberculosis in an ineffective therapy series, is applicable only in combination system name with other anti-TB measures. Indications for use drugs: treatment of infections Morphine or Morphine Sulfate by resistant M.tuberculosis, M. Method of production of drugs: cap. The effectiveness milliequivalent treatment of tuberculosis patients using clarithromycin, amoksytsyllin / klavulanovoyi acid, linezolid, some proven in randomized controlled trials (level of credibility of evidence D). In the event of serious Inferior Mesenteric Artery reactions that are not removed by pathogenic drug, cancel anti-TB drug system name caused this adverse reaction. Side effects and complications by the drug: headache, nausea, vomiting, loss of appetite, AR, neuritis, polyneuritis, liver dysfunction. Contraindications to the use of drugs: individual intolerance hemifloksatsynu and other fluoroquinolones, pregnancy and lactation, infancy to 18 years; QT-interval prolongation on system name including innate; tendon injury, moved earlier due to use of fluoroquinolones.
